These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
179 related articles for article (PubMed ID: 6222086)
41. [Oral 13-cis-retinoic acid therapy in adenoma sebaceum symmetricum and the most severe forms of acne and rosacea]. Vogt E; Friederich HC Z Hautkr; 1983 May; 58(9):646-67. PubMed ID: 6223455 [TBL] [Abstract][Full Text] [Related]
42. [13-cis retinoic acid in the oral therapy of acne conglobata. Results of a multi-center study]. Plewig G; Gollnick H; Meigel W; Wokalek H Hautarzt; 1981 Dec; 32(12):634-46. PubMed ID: 6459303 [No Abstract] [Full Text] [Related]
43. Qualitative and quantitative changes in cutaneous bacteria associated with systemic isotretinoin therapy for acne conglobata. Leyden JJ; McGinley KJ; Foglia AN J Invest Dermatol; 1986 Apr; 86(4):390-3. PubMed ID: 2943823 [TBL] [Abstract][Full Text] [Related]
44. Isotretinoin. A review of its pharmacological properties and therapeutic efficacy in acne and other skin disorders. Ward A; Brogden RN; Heel RC; Speight TM; Avery GS Drugs; 1984 Jul; 28(1):6-37. PubMed ID: 6235105 [TBL] [Abstract][Full Text] [Related]
45. Patterns of follicular sebum excretion rate during lifetime. Piérard GE; Piérard-Franchimont C; Lê T; Lapière C Arch Dermatol Res; 1987; 279 Suppl():S104-7. PubMed ID: 2959210 [TBL] [Abstract][Full Text] [Related]
46. The effect of a medicated wash on acne, sebum excretion rate and skin surface lipid composition. Cunliffe WJ; Cotterill JA; Williamson B Br J Dermatol; 1972 Mar; 86(3):311-2. PubMed ID: 4259713 [No Abstract] [Full Text] [Related]
47. A major advance in the treatment of severe acne. Jones DH J R Soc Med; 1985; 78 Suppl 10(Suppl 10):29-31. PubMed ID: 2941584 [No Abstract] [Full Text] [Related]
48. [13-cis-Retinoic acid. Pharmacologic and toxicologic findings in treatment of severe forms of acne (author's transl)]. Wagner A; Plewig G MMW Munch Med Wochenschr; 1980 Sep; 122(38):1294-300. PubMed ID: 6450894 [TBL] [Abstract][Full Text] [Related]
49. [Oral treatment of severe forms of acne with 13-cis-retinoic acid. Clinical results (author's transl)]. Plewig G; Wagner A; Braun-Falco O MMW Munch Med Wochenschr; 1980 Sep; 122(38):1287-93. PubMed ID: 6450893 [TBL] [Abstract][Full Text] [Related]
50. [New lipid biochemical aspects in the pathogenesis of a follicular keratinization disorder in acne vulgaris]. Melnik B; Plewig G Z Hautkr; 1988 Jul; 63(7):591-2, 595-6. PubMed ID: 2973184 [TBL] [Abstract][Full Text] [Related]
51. The role and mechanism of action of 13-cis-retinoic acid in the treatment of severe (nodulocystic) acne. Jones DH Pharmacol Ther; 1989; 40(1):91-106. PubMed ID: 2521954 [No Abstract] [Full Text] [Related]
52. Improved efficacy and tolerability of retinoic acid in acne vulgaris: a new topical formulation with cyclodextrin complex psi. Anadolu RY; Sen T; Tarimci N; Birol A; Erdem C J Eur Acad Dermatol Venereol; 2004 Jul; 18(4):416-21. PubMed ID: 15196153 [TBL] [Abstract][Full Text] [Related]
53. [Therapy of severe acne and acne rosacea with oral 13-cis-retinoic acid (Isotretinoin)]. Gandola M Acta Vitaminol Enzymol; 1984; 6(4):325-37. PubMed ID: 6241994 [TBL] [Abstract][Full Text] [Related]
54. Oral spironolactone improves acne vulgaris and reduces sebum excretion. Goodfellow A; Alaghband-Zadeh J; Carter G; Cream JJ; Holland S; Scully J; Wise P Br J Dermatol; 1984 Aug; 111(2):209-14. PubMed ID: 6235834 [TBL] [Abstract][Full Text] [Related]